Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
about
The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
P2860
Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Fluticasone is associated with ...... iers in a real-world analysis.
@en
Fluticasone is associated with ...... iers in a real-world analysis.
@nl
type
label
Fluticasone is associated with ...... iers in a real-world analysis.
@en
Fluticasone is associated with ...... iers in a real-world analysis.
@nl
prefLabel
Fluticasone is associated with ...... iers in a real-world analysis.
@en
Fluticasone is associated with ...... iers in a real-world analysis.
@nl
P2860
P1433
P1476
Fluticasone is associated with ...... iers in a real-world analysis.
@en
P2093
Daniel C Malone
Edward P Armstrong
P2860
P304
P356
10.1592/PHCO.22.13.1117.33515
P407
P577
2002-09-01T00:00:00Z